FACBC for Head and Neck Cancers

Stopped Change in Principal Investigator and protocol revisions delayed study start and ultimately the decision was made to cancel the study.

Conditions

• Cancers of the Head and Neck

Interventions

• DRUG: FACBC

Sponsor

Emory University